2,3,4,7,8-pentachlorodibenzofuran has been researched along with Liver Neoplasms in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Budinsky, RA; Fontaine, D; Landenberger, B; Paustenbach, D; Starr, TB | 1 |
| Aylward, LL; Gray, MN; Keenan, RE | 1 |
| Burrows, EP; Mitchell, WR | 1 |
3 other study(ies) available for 2,3,4,7,8-pentachlorodibenzofuran and Liver Neoplasms
| Article | Year |
|---|---|
Recommended relative potency factors for 2,3,4,7,8-pentachlorodibenzofuran: the impact of different dose metrics.
Topics: Area Under Curve; Benzofurans; Dose-Response Relationship, Drug; Humans; Liver Neoplasms; Monte Carlo Method; Tumor Cells, Cultured | 2006 |
Relative cancer potencies of selected dioxin-like compounds on a body-burden basis: comparison to current toxic equivalency factors (TEFs).
Topics: Adenoma, Liver Cell; Adipose Tissue; Animals; Benzofurans; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Body Burden; Carcinogenicity Tests; Cholangiocarcinoma; Digestive System Neoplasms; Humans; Liver; Liver Neoplasms; Lung; Models, Biological; Organ Size; Polychlorinated Biphenyls; Polychlorinated Dibenzodioxins; Risk Assessment | 2006 |
Nitroreduction of 2,4-dinitrotoluene in vitro by cytochrome P-450 induced H4IIE cells.
Topics: Animals; Aryl Hydrocarbon Hydroxylases; Benzofurans; Carcinoma, Hepatocellular; Cell Survival; Cytochrome P-450 Enzyme System; Dinitrobenzenes; Enzyme Induction; Liver Neoplasms; Luminescent Measurements; Mutagenicity Tests; Oxidation-Reduction; Rats; Spectrophotometry, Ultraviolet; Tumor Cells, Cultured | 1995 |